July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Patterns of Chronic Conditions and Their Association with Visual Impairment
Author Affiliations & Notes
  • Dandan Diane Zheng
    Dept. of Public Health Sciences, University of Miami, Miami, Florida, United States
  • Sharon L Christ
    Dept. of Human Development and Family Studies, Purdue University, West Lafayette, Indiana, United States
  • Byron L Lam
    Bascom Palmer Eye Institute, Miami, Florida, United States
  • Daniel J Feaster
    Dept. of Public Health Sciences, University of Miami, Miami, Florida, United States
  • Kathryn McCollister
    Dept. of Public Health Sciences, University of Miami, Miami, Florida, United States
  • David J Lee
    Dept. of Public Health Sciences, University of Miami, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Dandan Zheng, None; Sharon Christ, None; Byron Lam, None; Daniel Feaster, None; Kathryn McCollister, None; David Lee, None
  • Footnotes
    Support  NEI Grant F31EY025936
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1390. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dandan Diane Zheng, Sharon L Christ, Byron L Lam, Daniel J Feaster, Kathryn McCollister, David J Lee; Patterns of Chronic Conditions and Their Association with Visual Impairment. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1390.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose :
Visual impairment (VI) and visual disorders often co-occur with other disabling chronic conditions. This research identifies chronic disease patterns and their relationship to VI in a nationally representative sample.

Methods :
Using data from 387,780 participants aged 18 years and older of the National Health Interview Survey (NHIS) 2002-2014, we employed latent class analysis (LCA) technique to place participants into subgroups with different combinations of thirteen self-reported chronic illnesses. LCA is data driven and the groups are derived from participants who are homogenous in their disease patterns. Nine LCA models ranging from two to ten classes were evaluated. Chronic illness class membership was then used as a predictor of self-reported VI status using logistic regression and controlling for covariates.

Results :
LCA identified 5 different groups with 70% of the participants belonging to the “healthy group”. The other four groups represented various degrees and patterns of multi-morbidity. The “hypertensive group” (19.6% of the total sample) had high prevalence of hypertension (63%), arthritis (48%), and diabetes (20%). The “respiratory conditions group” (4.4%) had high prevalence of emphysema (48%) and asthma (46%). The “heart disease group” (3.6%) had high prevalence of coronary heart disease (70%), stroke (15%) and other heart conditions (85%). The “severely impaired group” (1.8%) had much higher prevalence of hypertension (89%), other heart conditions (68%), arthritis (83%), emphysema (50%), diabetes (48%) and hearing impairment (54%).
After controlling for survey design, age, gender, race, Hispanic origin, education, marital status, insurance, income, BMI, smoking and alcohol drinking status, compared to the healthy group, participants in all four groups had elevated risk of reporting VI: heart disease group (OR 3.19, 95% CI [2.92, 3.48]); hypertensive group (3.28 [3.10, 3.48]); respiratory condition group (4.08 [3.76,4.43]); and severely impaired group (10.2 [9.2, 11.28]).

Conclusions :
LCA is effective in identifying pattern of chronic conditions in the population. Individuals in all four multi-morbidity groups were at significantly elevated risk of VI. Assessing the multi-morbidity patterns and its relationship with VI is helpful to reduce healthcare utilization and improve quality of life in these high-risk populations.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×